FDA chief Tukaram flags huge price gaps in medical devices, seeks Centre’s intervention
India’s Food and Drug Administration head, Tukaram, warned of significant disparities between the actual cost and the declared maximum retail price of medical devices. He cited an intravenous set bought for ₹11.05 being listed at ₹325 and an infusion set purchased for ₹11 marked at ₹201. The official called for central government intervention to address these pricing gaps.